Acer Therapeutics Q4 EPS $(0.31) Up From $(0.50) YoY
Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.31) per share. This is a 38 percent increase over losses of $(0.50) per share from the same period last year.
Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.31) per share. This is a 38 percent increase over losses of $(0.50) per share from the same period last year.